21 October 2021>: Clinical Research
Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma
Chuyao Sun 12ADE , Miao Zhang 1BCF , Qiao Qiao 1ADE , Yanli Wang 1C*DOI: 10.12659/MSM.932126
Med Sci Monit 2021; 27:e932126
Table 2 PSM result in non-RS-immune group.
Matching variables | No RT | RT | P value |
---|---|---|---|
34 | 71 | ||
0.793 | |||
I | 2 | 7 | |
II | 25 | 50 | |
III | 7 | 14 | |
0.180 | |||
I | 3 | 1 | |
II | 1 | 4 | |
III | 11 | 17 | |
IV | 19 | 49 | |
0.367 | |||
No | 26 | 47 | |
Yes | 8 | 24 | |
0.769 | |||
Negative | 30 | 60 | |
Positive\close | 4 | 11 | |
0.504 | |||
No | 25 | 46 | |
Micro-invasion\gross invasion | 9 | 25 | |
0.661 | |||
No | 21 | 48 | |
Yes | 13 | 23 | |
– | |||
No | 34 | 71 | |
Yes | 0 | 0 | |
PSM – propensity score matching; RS – radiosensitive. |